Gestodene, ethinylestradiol (Dyolafem, Gestodene/ethinylestradiol Forrester)
Gestodene, ethinylestradiol
Forrester Pharma (Pty) Ltd
Registration
- Applicant
- Forrester Pharma (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Dyolafem Each active tablet contains GESTODENE 0,075 mg and ETHINYLESTRADIOL 0,030 mg | Not listed | 52101952/18.8/1019 | Registered | Not determined | None |
| Gestodene/ethinylestradiol 0,075/0,02 MG forrester Each active tablet contains GESTODENE 0,075 mg and ETHINYLESTRADIOL 0,020 mg | 0,075/0,02 MG | 52102052/18.8/1020 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.